Found in water all over the world, PFAS are a group of
chemicals generated by industrial operations that have been linked to adverse
health effects. They are subject to escalating regulatory action by the Biden
Administration and the EPA due to their inability to break down naturally in
the environment and their impacts on human health. Also known as “forever
chemicals”, PFAS have been linked to cancer, developmental delays, hormone
disorders, and more. According to Washington DC based Environmental Working
Group, PFAS has been founding in water in over 2,800 locations in the United
States.
Previously, the company reported that the AEC had been shown
to reduce the levels of several PFAS compounds present in water provided by the
prospective municipal client to below State and Federal standards. These new results
prove that the AEC has removed multiple PFAS compounds to below the limit of
quantification (i.e., functionally eliminated) following optimization of the
AEC’s membranes and contact time.
Randall Moore, President of BioLargo Engineering, Science
& Technologies commented, “These results confirm not only that the AEC can
deliver virtually total elimination of PFAS from contaminated drinking water,
but that the technology can, with relative ease, be fine-tuned to achieve varying
levels of treatment performance as prescribed by a client’s own treatment goals
and regulatory needs.”
Tonya Chandler, Director of Strategic Marketing and Business
Development at BioLargo, commented, “These results show that the AEC is an
effective solution for customers seeking PFAS water treatment and removal, and
will be integral as we advance to commercial trials and first sales of the
technology. Our AEC system is capable of total PFAS elimination while
generating less than 1/1000 the volume of PFAS-laden waste product compared to carbon
filtration, the most common solution in the market today. No one wants to trade
one environmental disaster for another, and the AEC helps avoid the trailing
environmental impact and significant cost associated with disposal of PFAS-laden
carbon.”
To learn more about BioLargo’s AEC technology, visit https://www.biolargoengineering.com/biolargo-aec/.
About BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO) invents, develops, and
commercializes innovative platform technologies to solve challenging
environmental problems like PFAS contamination, advanced water and wastewater
treatment, industrial odor and VOC control, air quality control, and infection
control. With over 13 years of extensive R&D, BioLargo holds a wide array
of issued patents, maintains a robust pipeline of products, and provides full-service
environmental engineering. Our peer-reviewed scientific approach allows us to
invent or acquire novel technologies and develop them to maturity through our
operating subsidiaries. With a keen emphasis on collaborations with academic,
municipal, and commercial organizations and associations, BioLargo has proven
itself with over 80 awarded grants and numerous pilot projects. We monetize
through direct sales, recurring service contracts, licensing agreements,
strategic joint venture formation and/or the sale of the IP. See our website at
www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements include without limitation those about BioLargo’s
(the “Company”) expectations regarding the impact of the COVID-19 pandemic;
anticipated revenue; and plans for future operations. These statements involve
risks and uncertainties, and actual results may differ materially from any
future results expressed or implied by the forward-looking statements. Risks
and uncertainties include without limitation: the effect of the COVID-19
pandemic on the Company’s business, results of operations, financial condition,
and stock price; the effect of regional economic conditions on the Company’s
business, including effects on purchasing decisions by consumers and businesses;
the ability of the Company to compete in markets that are highly competitive
and subject to rapid technological change; the ability of the Company to manage
frequent introductions and transitions of products and services, including
delivering to the marketplace, and stimulating customer demand for, new
products, services, and technological innovations on a timely basis; the
dependency of the Company on the performance of distributors of the Company’s
products. More information on these risks and other potential factors that
could affect the Company’s business and financial results is included in the
Company’s filings with the SEC, including in the “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and Results of
Operations” sections of the Company’s most recently filed periodic reports on
Form 10-K and Form 10-Q and subsequent filings. The Company assumes no
obligation to update any forward-looking statements or information, which speak
as of their respective dates.
